Subscribe to Newsletter

Content by Stephanie Vine:

Business & Regulation Profession

From Benchtop Chemist to CEO

| Stephanie Vine | 5 min read

Simon Tasker joined Colorcon as a bench chemist – and never left. Today, he’s the company’s CEO. Here’s how his career unfolded.

Manufacture Advanced Medicine

Cell Therapy: Getting GMP Right

| Stephanie Vine | 2 min read

Open-access research paper outlines quality and regulatory considerations for cell therapy manufacturing programs.

Business & Regulation Profession

The Blood Cancer Success Story: Part 2

| Stephanie Vine | 6 min read

Lore Gruenbaum discusses The Leukemia & Lymphoma Society, advances in blood cancers, and the role of nonprofits.

Discovery & Development Drug Discovery

Three Amazing Medicine Making Stories

| Stephanie Vine | 3 min read

Ivermectin, Viagra and warfarin; I look at the origins of three popular drugs and the role of serendipity.

Discovery & Development Drug Discovery

The Shingles Vaccine and Dementia

| Stephanie Vine | 2 min read

Studies have suggested that the RZV shingles vaccine can lower the risk of dementia; GSK is now investigating further.

Business & Regulation Standards & Regulation

Trump Speech Suggests Pharma Tariffs Incoming

| Stephanie Vine | 2 min read

Donald Trump threatens “major tariff” on pharmaceuticals.

Business & Regulation Profession

The Blood Cancer Success Story: Part 1

| Stephanie Vine | 7 min read

Lore Gruenbaum tells us about her career spanning big pharma, biotech and now The Leukemia & Lymphoma Society.

Business & Regulation Standards & Regulation

Is the FDA About to Break?

| Stephanie Vine | 3 min read

Job cuts at the FDA spark concern, with Robert Califf saying the agency as we know it is “finished.”

Business & Regulation Trends & Forecasts

The Economics of Biosimilars

| Stephanie Vine | 7 min read

We ask James Chambers from Tufts Medical Center about the challenges faced by biosimilars in the US.

Discovery & Development Drug Delivery

Squid-Inspired Drug Delivery

| Stephanie Vine | 4 min read

Here’s how researchers took lessons from cephalopods to develop a new capsule that can deliver drugs, including insulin and siRNA, orally.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker